Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Dyne Therapeutics, Inc. Common Stock (DYN)

Dyne Therapeutics announces positive topline results from its Phase 1/2 DELIVER trial for z-rostudirsen in Duchenne muscular dystrophy, potentially offering a more effective alternative to current therapies. The company plans to file for approval, with analysts raising price targets.

### About Dyne Therapeutics, Inc. Common Stock
Dyne Therapeutics, Inc. is a biotechnology company focused on developing therapies for neuromuscular disorders.  
Dyne Therapeutics, Inc. Common Stock uses the ticker $DYN for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Dyne Therapeutics, Inc. Common Stock (DYN) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Dyne Therapeutics, Inc. Common Stock (DYN) engagements hit 36.3K which is XXX% higher than it's daily average.
- Dyne Therapeutics, Inc. Common Stock (DYN) trading volume is up XXXXXX% from the previous week.
- Dyne Therapeutics, Inc. Common Stock (DYN) social dominance is up XXXXXX% from the previous week.
- Dyne Therapeutics, Inc. Common Stock (DYN) engagements is up XXXXXX% from the previous week.
- Dyne Therapeutics, Inc. Common Stock (DYN) posts created is up XXXXXX% from the previous week.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/close.tsv)  
The stock price is currently influenced by positive clinical trial data and FDA designations, but tempered by valuation concerns, leading to a recent pullback after gains. Social media indicates mixed sentiment with analyst target raises and institutional interest.  

24-Hour: -XXXXX%
7-Day: -XXXXX%
30-Day: -XXXX%

1-Year High: $XXXXX on 2024-12-11  
1-Year Low: $XXXX on 2025-04-08  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/alt_rank.tsv)  
Dyne Therapeutics, Inc. Common Stock (DYN) is currently AltRank #150 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX -XXX  
X Month: XXX -XXX  
X Months: XXX -XXX  
X Year: XXX -XXX  
1-Year High: XXXXX on 2025-09-15  
1-Year Low: X on 2024-12-28  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -X  
X Month: XX -X  
X Months: XX -X  
X Year: XX -XX  
1-Year High: XX on 2025-12-08  
1-Year Low: XX on 2025-12-03  
  
  
### Engagements: XXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/interactions.tsv)  
Current Value: XXXXXX  
Daily Average: XXXXX  
X Week: XXXXXX +432%  
X Month: XXXXXXX +23%  
X Months: XXXXXXXXX -XX%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-04-25  
1-Year Low: XXX on 2025-12-06  

Engagements by network (24h):
Reddit: XX
X: XXXXXX
YouTube: XX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +8.30%  
X Year: XXXXX +5.70%  
1-Year High: XXX on 2025-10-27  
1-Year Low: X on 2025-09-14  

Mentions by network (24h):
Reddit: X
X: XXXXX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Dyne Therapeutics, Inc. Common Stock (DYN) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +120%  
X Year: XXXXX +74%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-09-14  

The most influential creators that mention Dyne Therapeutics, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@adamfeuerstein](/creator/twitter/adamfeuerstein)   | X    | XXXXXXX   | X     | XXXXXX      |
| [@BioStocks](/creator/twitter/BioStocks)             | X    | XXXXXX    | X     | XXXXX       |
| [@semodough](/creator/twitter/semodough)             | X    | XXXXXX    | X     | XXXXX       |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)         | X    | XXXXXX    | XX    | XXXXX       |
| [@monaco_biotech](/creator/twitter/monaco_biotech)   | X    | XXXXX     | X     | XXX         |
| [@FrenzyCapital](/creator/twitter/FrenzyCapital)     | X    | XXXXX     | XX    | XXX         |
| [@Hall8Jack](/creator/twitter/Hall8Jack)             | X    | XXXXX     | X     | XXX         |
| [@bioinvestor24](/creator/twitter/bioinvestor24)     | X    | XXXXX     | X     | XXX         |
| [@OzmosiHealth](/creator/twitter/OzmosiHealth)       | X    | XXXXX     | X     | XXX         |
| [@BiotechAnalysst](/creator/twitter/BiotechAnalysst) | XX   | XXXXX     | X     | XXX         |

[View More](/list/creators/dyne-therapeutics/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% +13%  
X Months: XX% +8%  
X Year: XX% -X%  
1-Year High: XXX% on 2025-10-18  
1-Year Low: XX% on 2025-01-04  

Most Supportive Themes:
- Positive Clinical Data and FDA Designation: (40%) Dyne Therapeutics' ACHIEVE trial for DM1 and FDA breakthrough designations are driving positive sentiment.
- Favorable Analyst Ratings: (30%) Analyst ratings and price targets, with a consensus of Strong Buy and potential upside, are supporting the stock.
- Institutional Ownership: (30%) High institutional ownership and confidence from major funds are contributing to a positive outlook.
  
Most Critical Themes:
- Valuation Concerns: (100%) Downgrades from some analysts and concerns about valuation are creating caution despite promising clinical data.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.047%  
X Month: XXXXX% +0.042%  
X Months: XXXXX% +0.035%  
X Year: XXXXX% +0.0064%  
1-Year High: XXXXX% on 2025-04-29  
1-Year Low: XXXXXX% on 2025-09-14  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-11-24  
1-Year Low: XXXXXXX% on 2025-03-14  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX -$10%  
X Month: $XXXXXXXXXXXXX +$0.76%  
X Months: $XXXXXXXXXXXXX +$61%  
X Year: $XXXXXXXXXXXXX -$9.40%  
1-Year High: $XXXXXXXXXXXXX on 2025-10-28  
1-Year Low: $XXXXXXXXXXX on 2025-04-08  

### Top Dyne Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"#Biotech offerings priced - $TERN $650M at $40/share $GPCR $650M at $65/ADS $KYMR $602M at $86/share $WVE $350M at $19/share $DYN $350M at $18.44/share $VERA $261M at $42.50/share $XXXX BillionšŸ’„ $XBI"  
[X Link](https://x.com/BioStocks/status/1998615636621279382) [@BioStocks](/creator/x/BioStocks) 2025-12-10T04:47Z 70.4K followers, 5063 engagements


"$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1998503198491918364) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-09T21:21Z 3011 followers, XXX engagements


"Midday Fly By: Nvidia can ship H200s to China Campbell's reports Q1 beat $FERG $VIK $NCLH $CL $VRT $SNPS $SLM $DIS $BAC $C $APO $PSKY $WBD $ACN $CWAN $CPNG $ALEX $TROX $STAA $AA $PHR $CNM $DBI $LE $GIII $DYN $NVDA $HD $CVS $F $RNLSY $RNSDF $CPB"  
[X Link](https://x.com/theflynews/status/1998451893110997190) [@theflynews](/creator/x/theflynews) 2025-12-09T17:57Z 28.8K followers, XXX engagements


"Biggest Losers: $FERG $BEKE $SMMT $KYMR $SLM $GPK $KTB $WRD $AAP $DYN $OLMA"  
[X Link](https://x.com/FrenzyCapital/status/1998422512296755396) [@FrenzyCapital](/creator/x/FrenzyCapital) 2025-12-09T16:00Z 1563 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Dyne Therapeutics, Inc. Common Stock (DYN)

Dyne Therapeutics announces positive topline results from its Phase 1/2 DELIVER trial for z-rostudirsen in Duchenne muscular dystrophy, potentially offering a more effective alternative to current therapies. The company plans to file for approval, with analysts raising price targets.

About Dyne Therapeutics, Inc. Common Stock

Dyne Therapeutics, Inc. is a biotechnology company focused on developing therapies for neuromuscular disorders.
Dyne Therapeutics, Inc. Common Stock uses the ticker $DYN for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Dyne Therapeutics, Inc. Common Stock (DYN) social dominance hit XXXXXX which is XXX% higher than it's daily average.
  • Dyne Therapeutics, Inc. Common Stock (DYN) engagements hit 36.3K which is XXX% higher than it's daily average.
  • Dyne Therapeutics, Inc. Common Stock (DYN) trading volume is up XXXXXX% from the previous week.
  • Dyne Therapeutics, Inc. Common Stock (DYN) social dominance is up XXXXXX% from the previous week.
  • Dyne Therapeutics, Inc. Common Stock (DYN) engagements is up XXXXXX% from the previous week.
  • Dyne Therapeutics, Inc. Common Stock (DYN) posts created is up XXXXXX% from the previous week.

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price is currently influenced by positive clinical trial data and FDA designations, but tempered by valuation concerns, leading to a recent pullback after gains. Social media indicates mixed sentiment with analyst target raises and institutional interest.

24-Hour: -XXXXX% 7-Day: -XXXXX% 30-Day: -XXXX%

1-Year High: $XXXXX on 2024-12-11
1-Year Low: $XXXX on 2025-04-08

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Dyne Therapeutics, Inc. Common Stock (DYN) is currently AltRank #150 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XXX
X Month: XXX -XXX
X Months: XXX -XXX
X Year: XXX -XXX
1-Year High: XXXXX on 2025-09-15
1-Year Low: X on 2024-12-28

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -X
X Months: XX -X
X Year: XX -XX
1-Year High: XX on 2025-12-08
1-Year Low: XX on 2025-12-03

Engagements: XXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXX
X Week: XXXXXX +432%
X Month: XXXXXXX +23%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-04-25
1-Year Low: XXX on 2025-12-06

Engagements by network (24h): Reddit: XX X: XXXXXX YouTube: XX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +8.30%
X Year: XXXXX +5.70%
1-Year High: XXX on 2025-10-27
1-Year Low: X on 2025-09-14

Mentions by network (24h): Reddit: X X: XXXXX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Dyne Therapeutics, Inc. Common Stock (DYN) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +120%
X Year: XXXXX +74%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-14

The most influential creators that mention Dyne Therapeutics, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@adamfeuerstein X XXXXXXX X XXXXXX
@BioStocks X XXXXXX X XXXXX
@semodough X XXXXXX X XXXXX
@RNAiAnalyst X XXXXXX XX XXXXX
@monaco_biotech X XXXXX X XXX
@FrenzyCapital X XXXXX XX XXX
@Hall8Jack X XXXXX X XXX
@bioinvestor24 X XXXXX X XXX
@OzmosiHealth X XXXXX X XXX
@BiotechAnalysst XX XXXXX X XXX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% +13%
X Months: XX% +8%
X Year: XX% -X%
1-Year High: XXX% on 2025-10-18
1-Year Low: XX% on 2025-01-04

Most Supportive Themes:

  • Positive Clinical Data and FDA Designation: (40%) Dyne Therapeutics' ACHIEVE trial for DM1 and FDA breakthrough designations are driving positive sentiment.
  • Favorable Analyst Ratings: (30%) Analyst ratings and price targets, with a consensus of Strong Buy and potential upside, are supporting the stock.
  • Institutional Ownership: (30%) High institutional ownership and confidence from major funds are contributing to a positive outlook.

Most Critical Themes:

  • Valuation Concerns: (100%) Downgrades from some analysts and concerns about valuation are creating caution despite promising clinical data.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.047%
X Month: XXXXX% +0.042%
X Months: XXXXX% +0.035%
X Year: XXXXX% +0.0064%
1-Year High: XXXXX% on 2025-04-29
1-Year Low: XXXXXX% on 2025-09-14

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-24
1-Year Low: XXXXXXX% on 2025-03-14

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$10%
X Month: $XXXXXXXXXXXXX +$0.76%
X Months: $XXXXXXXXXXXXX +$61%
X Year: $XXXXXXXXXXXXX -$9.40%
1-Year High: $XXXXXXXXXXXXX on 2025-10-28
1-Year Low: $XXXXXXXXXXX on 2025-04-08

Top Dyne Therapeutics, Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"#Biotech offerings priced - $TERN $650M at $40/share $GPCR $650M at $65/ADS $KYMR $602M at $86/share $WVE $350M at $19/share $DYN $350M at $18.44/share $VERA $261M at $42.50/share $XXXX BillionšŸ’„ $XBI"
X Link @BioStocks 2025-12-10T04:47Z 70.4K followers, 5063 engagements

"$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:"
X Link @OzmosiHealth 2025-12-09T21:21Z 3011 followers, XXX engagements

"Midday Fly By: Nvidia can ship H200s to China Campbell's reports Q1 beat $FERG $VIK $NCLH $CL $VRT $SNPS $SLM $DIS $BAC $C $APO $PSKY $WBD $ACN $CWAN $CPNG $ALEX $TROX $STAA $AA $PHR $CNM $DBI $LE $GIII $DYN $NVDA $HD $CVS $F $RNLSY $RNSDF $CPB"
X Link @theflynews 2025-12-09T17:57Z 28.8K followers, XXX engagements

"Biggest Losers: $FERG $BEKE $SMMT $KYMR $SLM $GPK $KTB $WRD $AAP $DYN $OLMA"
X Link @FrenzyCapital 2025-12-09T16:00Z 1563 followers, XXX engagements

Dyne Therapeutics, Inc. Common Stock (DYN)
/topic/dyne-therapeutics